Home>Services >Biopharmaceutical Manufacturing Services>End-to-End - A Molecule’s Journey

A Molecule’s Journey

Break Down Roadblocks to Commercial Success

A guidebook for today’s biopharma executives seeking to navigate through the important considerations necessary to successfully build their own GMP biomanufacturing facility

Every biopharma executive must make important decisions early in clinical development that will impact their molecule’s journey – and ultimately the success of their commercial strategy. The key to this success is to make the right decisions at the right time.

Get your Guidebook

In this guidebook, our experts share some key considerations for designing, building and operating an agile and flexible GMP biomanufacturing facility successfully, safely, and profitably. To achieve this goal, companies must first overcome some common roadblocks and navigate the complexities associated with business planning, technology, regulatory/risk assessment and engineering.

Martillac, France Facility

Case Study

Building a Fully Single-Use GMP Biomanufacturing Facility in Martillac, France

In 2011, we converted a stainless steel good manufacturing practice (GMP) bioproduction facility in Martillac, France into a state-of-the-art, fully single-use GMP facility, providing clients with increased speed to clinic. In this case study, we share with you some critical success factors and lessons learned.

Your Trusted Partner

Learn more about BioReliance® End-to-End Solutions:

As a trusted partner, we facilitate success by enabling our clients through provision of flexible solutions and guidance based upon first-hand experience.